Click for best price
Adult Pediatric Vaccines Market Size, Share 2022
A vaccine is a biological preparation that provides active acquired immunity to a particular disease.
This report contains market size and forecasts of Adult and Pediatric Vaccines in Global, including the following market information:
Global Adult and Pediatric Vaccines Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Adult and Pediatric Vaccines market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Adult Vaccines Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Adult and Pediatric Vaccines include GlaxoSmithKline, Sanofi, Merck, Novartis, Pfizer, AstraZeneca, Johnson and Johnson, Takeda Pharmaceutical and Bavarian Nordic, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Adult and Pediatric Vaccines companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Adult and Pediatric Vaccines Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Adult and Pediatric Vaccines Market Segment Percentages, by Type, 2021 (%)
Adult Vaccines
Pediatric Vaccines
Global Adult and Pediatric Vaccines Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Adult and Pediatric Vaccines Market Segment Percentages, by Application, 2021 (%)
Hospitals
Medical Care Centers
Others
Global Adult and Pediatric Vaccines Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Adult and Pediatric Vaccines Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Adult and Pediatric Vaccines revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Adult and Pediatric Vaccines revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
GlaxoSmithKline
Sanofi
Merck
Novartis
Pfizer
AstraZeneca
Johnson and Johnson
Takeda Pharmaceutical
Bavarian Nordic
LG Life Sciences
Sinovac Biotech
| Report Attributes |
Report Details |
| Report Title |
Adult and Pediatric Vaccines Market - Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
61 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Adult and Pediatric Vaccines Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Adult and Pediatric Vaccines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Adult and Pediatric Vaccines Overall Market Size
2.1 Global Adult and Pediatric Vaccines Market Size: 2021 VS 2028
2.2 Global Adult and Pediatric Vaccines Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Adult and Pediatric Vaccines Players in Global Market
3.2 Top Global Adult and Pediatric Vaccines Companies Ranked by Revenue
3.3 Global Adult and Pediatric Vaccines Revenue by Companies
3.4 Top 3 and Top 5 Adult and Pediatric Vaccines Companies in Global Market, by Revenue in 2021
3.5 Global Companies Adult and Pediatric Vaccines Product Type
3.6 Tier 1, Tier 2 and Tier 3 Adult and Pediatric Vaccines Players in Global Market
3.6.1 List of Global Tier 1 Adult and Pediatric Vaccines Companies
3.6.2 List of Global Tier 2 and Tier 3 Adult and Pediatric Vaccines Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Adult and Pediatric Vaccines Market Size Markets, 2021 & 2028
4.1.2 Adult Vaccines
4.1.3 Pediatric Vaccines
4.2 By Type - Global Adult and Pediatric Vaccines Revenue & Forecasts
4.2.1 By Type - Global Adult and Pediatric Vaccines Revenue, 2017-2022
4.2.2 By Type - Global Adult and Pediatric Vaccines Revenue, 2023-2028
4.2.3 By Type - Global Adult and Pediatric Vaccines Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Adult and Pediatric Vaccines Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Medical Care Centers
5.1.4 Others
5.2 By Application - Global Adult and Pediatric Vaccines Revenue & Forecasts
5.2.1 By Application - Global Adult and Pediatric Vaccines Revenue, 2017-2022
5.2.2 By Application - Global Adult and Pediatric Vaccines Revenue, 2023-2028
5.2.3 By Application - Global Adult and Pediatric Vaccines Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Adult and Pediatric Vaccines Market Size, 2021 & 2028
6.2 By Region - Global Adult and Pediatric Vaccines Revenue & Forecasts
6.2.1 By Region - Global Adult and Pediatric Vaccines Revenue, 2017-2022
6.2.2 By Region - Global Adult and Pediatric Vaccines Revenue, 2023-2028
6.2.3 By Region - Global Adult and Pediatric Vaccines Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Adult and Pediatric Vaccines Revenue, 2017-2028
6.3.2 US Adult and Pediatric Vaccines Market Size, 2017-2028
6.3.3 Canada Adult and Pediatric Vaccines Market Size, 2017-2028
6.3.4 Mexico Adult and Pediatric Vaccines Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Adult and Pediatric Vaccines Revenue, 2017-2028
6.4.2 Germany Adult and Pediatric Vaccines Market Size, 2017-2028
6.4.3 France Adult and Pediatric Vaccines Market Size, 2017-2028
6.4.4 U.K. Adult and Pediatric Vaccines Market Size, 2017-2028
6.4.5 Italy Adult and Pediatric Vaccines Market Size, 2017-2028
6.4.6 Russia Adult and Pediatric Vaccines Market Size, 2017-2028
6.4.7 Nordic Countries Adult and Pediatric Vaccines Market Size, 2017-2028
6.4.8 Benelux Adult and Pediatric Vaccines Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Adult and Pediatric Vaccines Revenue, 2017-2028
6.5.2 China Adult and Pediatric Vaccines Market Size, 2017-2028
6.5.3 Japan Adult and Pediatric Vaccines Market Size, 2017-2028
6.5.4 South Korea Adult and Pediatric Vaccines Market Size, 2017-2028
6.5.5 Southeast Asia Adult and Pediatric Vaccines Market Size, 2017-2028
6.5.6 India Adult and Pediatric Vaccines Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Adult and Pediatric Vaccines Revenue, 2017-2028
6.6.2 Brazil Adult and Pediatric Vaccines Market Size, 2017-2028
6.6.3 Argentina Adult and Pediatric Vaccines Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Adult and Pediatric Vaccines Revenue, 2017-2028
6.7.2 Turkey Adult and Pediatric Vaccines Market Size, 2017-2028
6.7.3 Israel Adult and Pediatric Vaccines Market Size, 2017-2028
6.7.4 Saudi Arabia Adult and Pediatric Vaccines Market Size, 2017-2028
6.7.5 UAE Adult and Pediatric Vaccines Market Size, 2017-2028
7 Players Profiles
7.1 GlaxoSmithKline
7.1.1 GlaxoSmithKline Corporate Summary
7.1.2 GlaxoSmithKline Business Overview
7.1.3 GlaxoSmithKline Adult and Pediatric Vaccines Major Product Offerings
7.1.4 GlaxoSmithKline Adult and Pediatric Vaccines Revenue in Global Market (2017-2022)
7.1.5 GlaxoSmithKline Key News
7.2 Sanofi
7.2.1 Sanofi Corporate Summary
7.2.2 Sanofi Business Overview
7.2.3 Sanofi Adult and Pediatric Vaccines Major Product Offerings
7.2.4 Sanofi Adult and Pediatric Vaccines Revenue in Global Market (2017-2022)
7.2.5 Sanofi Key News
7.3 Merck
7.3.1 Merck Corporate Summary
7.3.2 Merck Business Overview
7.3.3 Merck Adult and Pediatric Vaccines Major Product Offerings
7.3.4 Merck Adult and Pediatric Vaccines Revenue in Global Market (2017-2022)
7.3.5 Merck Key News
7.4 Novartis
7.4.1 Novartis Corporate Summary
7.4.2 Novartis Business Overview
7.4.3 Novartis Adult and Pediatric Vaccines Major Product Offerings
7.4.4 Novartis Adult and Pediatric Vaccines Revenue in Global Market (2017-2022)
7.4.5 Novartis Key News
7.5 Pfizer
7.5.1 Pfizer Corporate Summary
7.5.2 Pfizer Business Overview
7.5.3 Pfizer Adult and Pediatric Vaccines Major Product Offerings
7.5.4 Pfizer Adult and Pediatric Vaccines Revenue in Global Market (2017-2022)
7.5.5 Pfizer Key News
7.6 AstraZeneca
7.6.1 AstraZeneca Corporate Summary
7.6.2 AstraZeneca Business Overview
7.6.3 AstraZeneca Adult and Pediatric Vaccines Major Product Offerings
7.6.4 AstraZeneca Adult and Pediatric Vaccines Revenue in Global Market (2017-2022)
7.6.5 AstraZeneca Key News
7.7 Johnson and Johnson
7.7.1 Johnson and Johnson Corporate Summary
7.7.2 Johnson and Johnson Business Overview
7.7.3 Johnson and Johnson Adult and Pediatric Vaccines Major Product Offerings
7.7.4 Johnson and Johnson Adult and Pediatric Vaccines Revenue in Global Market (2017-2022)
7.7.5 Johnson and Johnson Key News
7.8 Takeda Pharmaceutical
7.8.1 Takeda Pharmaceutical Corporate Summary
7.8.2 Takeda Pharmaceutical Business Overview
7.8.3 Takeda Pharmaceutical Adult and Pediatric Vaccines Major Product Offerings
7.8.4 Takeda Pharmaceutical Adult and Pediatric Vaccines Revenue in Global Market (2017-2022)
7.8.5 Takeda Pharmaceutical Key News
7.9 Bavarian Nordic
7.9.1 Bavarian Nordic Corporate Summary
7.9.2 Bavarian Nordic Business Overview
7.9.3 Bavarian Nordic Adult and Pediatric Vaccines Major Product Offerings
7.9.4 Bavarian Nordic Adult and Pediatric Vaccines Revenue in Global Market (2017-2022)
7.9.5 Bavarian Nordic Key News
7.10 LG Life Sciences
7.10.1 LG Life Sciences Corporate Summary
7.10.2 LG Life Sciences Business Overview
7.10.3 LG Life Sciences Adult and Pediatric Vaccines Major Product Offerings
7.10.4 LG Life Sciences Adult and Pediatric Vaccines Revenue in Global Market (2017-2022)
7.10.5 LG Life Sciences Key News
7.11 Sinovac Biotech
7.11.1 Sinovac Biotech Corporate Summary
7.11.2 Sinovac Biotech Business Overview
7.11.3 Sinovac Biotech Adult and Pediatric Vaccines Major Product Offerings
7.11.4 Sinovac Biotech Adult and Pediatric Vaccines Revenue in Global Market (2017-2022)
7.11.5 Sinovac Biotech Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Adult and Pediatric Vaccines Market Opportunities & Trends in Global Market
Table 2. Adult and Pediatric Vaccines Market Drivers in Global Market
Table 3. Adult and Pediatric Vaccines Market Restraints in Global Market
Table 4. Key Players of Adult and Pediatric Vaccines in Global Market
Table 5. Top Adult and Pediatric Vaccines Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Adult and Pediatric Vaccines Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Adult and Pediatric Vaccines Revenue Share by Companies, 2017-2022
Table 8. Global Companies Adult and Pediatric Vaccines Product Type
Table 9. List of Global Tier 1 Adult and Pediatric Vaccines Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Adult and Pediatric Vaccines Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Adult and Pediatric Vaccines Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Adult and Pediatric Vaccines Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Adult and Pediatric Vaccines Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Adult and Pediatric Vaccines Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Adult and Pediatric Vaccines Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Adult and Pediatric Vaccines Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Adult and Pediatric Vaccines Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Adult and Pediatric Vaccines Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Adult and Pediatric Vaccines Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Adult and Pediatric Vaccines Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Adult and Pediatric Vaccines Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Adult and Pediatric Vaccines Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Adult and Pediatric Vaccines Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Adult and Pediatric Vaccines Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Adult and Pediatric Vaccines Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Adult and Pediatric Vaccines Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Adult and Pediatric Vaccines Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Adult and Pediatric Vaccines Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Adult and Pediatric Vaccines Revenue, (US$, Mn), 2023-2028
Table 30. GlaxoSmithKline Corporate Summary
Table 31. GlaxoSmithKline Adult and Pediatric Vaccines Product Offerings
Table 32. GlaxoSmithKline Adult and Pediatric Vaccines Revenue (US$, Mn), (2017-2022)
Table 33. Sanofi Corporate Summary
Table 34. Sanofi Adult and Pediatric Vaccines Product Offerings
Table 35. Sanofi Adult and Pediatric Vaccines Revenue (US$, Mn), (2017-2022)
Table 36. Merck Corporate Summary
Table 37. Merck Adult and Pediatric Vaccines Product Offerings
Table 38. Merck Adult and Pediatric Vaccines Revenue (US$, Mn), (2017-2022)
Table 39. Novartis Corporate Summary
Table 40. Novartis Adult and Pediatric Vaccines Product Offerings
Table 41. Novartis Adult and Pediatric Vaccines Revenue (US$, Mn), (2017-2022)
Table 42. Pfizer Corporate Summary
Table 43. Pfizer Adult and Pediatric Vaccines Product Offerings
Table 44. Pfizer Adult and Pediatric Vaccines Revenue (US$, Mn), (2017-2022)
Table 45. AstraZeneca Corporate Summary
Table 46. AstraZeneca Adult and Pediatric Vaccines Product Offerings
Table 47. AstraZeneca Adult and Pediatric Vaccines Revenue (US$, Mn), (2017-2022)
Table 48. Johnson and Johnson Corporate Summary
Table 49. Johnson and Johnson Adult and Pediatric Vaccines Product Offerings
Table 50. Johnson and Johnson Adult and Pediatric Vaccines Revenue (US$, Mn), (2017-2022)
Table 51. Takeda Pharmaceutical Corporate Summary
Table 52. Takeda Pharmaceutical Adult and Pediatric Vaccines Product Offerings
Table 53. Takeda Pharmaceutical Adult and Pediatric Vaccines Revenue (US$, Mn), (2017-2022)
Table 54. Bavarian Nordic Corporate Summary
Table 55. Bavarian Nordic Adult and Pediatric Vaccines Product Offerings
Table 56. Bavarian Nordic Adult and Pediatric Vaccines Revenue (US$, Mn), (2017-2022)
Table 57. LG Life Sciences Corporate Summary
Table 58. LG Life Sciences Adult and Pediatric Vaccines Product Offerings
Table 59. LG Life Sciences Adult and Pediatric Vaccines Revenue (US$, Mn), (2017-2022)
Table 60. Sinovac Biotech Corporate Summary
Table 61. Sinovac Biotech Adult and Pediatric Vaccines Product Offerings
Table 62. Sinovac Biotech Adult and Pediatric Vaccines Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Adult and Pediatric Vaccines Segment by Type in 2021
Figure 2. Adult and Pediatric Vaccines Segment by Application in 2021
Figure 3. Global Adult and Pediatric Vaccines Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Adult and Pediatric Vaccines Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Adult and Pediatric Vaccines Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Adult and Pediatric Vaccines Revenue in 2021
Figure 8. By Type - Global Adult and Pediatric Vaccines Revenue Market Share, 2017-2028
Figure 9. By Application - Global Adult and Pediatric Vaccines Revenue Market Share, 2017-2028
Figure 10. By Region - Global Adult and Pediatric Vaccines Revenue Market Share, 2017-2028
Figure 11. By Country - North America Adult and Pediatric Vaccines Revenue Market Share, 2017-2028
Figure 12. US Adult and Pediatric Vaccines Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Adult and Pediatric Vaccines Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Adult and Pediatric Vaccines Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Adult and Pediatric Vaccines Revenue Market Share, 2017-2028
Figure 16. Germany Adult and Pediatric Vaccines Revenue, (US$, Mn), 2017-2028
Figure 17. France Adult and Pediatric Vaccines Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Adult and Pediatric Vaccines Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Adult and Pediatric Vaccines Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Adult and Pediatric Vaccines Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Adult and Pediatric Vaccines Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Adult and Pediatric Vaccines Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Adult and Pediatric Vaccines Revenue Market Share, 2017-2028
Figure 24. China Adult and Pediatric Vaccines Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Adult and Pediatric Vaccines Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Adult and Pediatric Vaccines Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Adult and Pediatric Vaccines Revenue, (US$, Mn), 2017-2028
Figure 28. India Adult and Pediatric Vaccines Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Adult and Pediatric Vaccines Revenue Market Share, 2017-2028
Figure 30. Brazil Adult and Pediatric Vaccines Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Adult and Pediatric Vaccines Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Adult and Pediatric Vaccines Revenue Market Share, 2017-2028
Figure 33. Turkey Adult and Pediatric Vaccines Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Adult and Pediatric Vaccines Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Adult and Pediatric Vaccines Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Adult and Pediatric Vaccines Revenue, (US$, Mn), 2017-2028
Figure 37. GlaxoSmithKline Adult and Pediatric Vaccines Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Sanofi Adult and Pediatric Vaccines Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Merck Adult and Pediatric Vaccines Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Novartis Adult and Pediatric Vaccines Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Pfizer Adult and Pediatric Vaccines Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. AstraZeneca Adult and Pediatric Vaccines Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Johnson and Johnson Adult and Pediatric Vaccines Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Takeda Pharmaceutical Adult and Pediatric Vaccines Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Bavarian Nordic Adult and Pediatric Vaccines Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. LG Life Sciences Adult and Pediatric Vaccines Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Sinovac Biotech Adult and Pediatric Vaccines Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
